Drug information for LEUSTATIN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
1MG/ML
Prescription
AP (Reference Drug)
CLADRIBINE
Cladribine
JANSSEN PHARMS
20229
2006-07-03 Letter
2002-08-22 Letter
2002-08-20 Letter
2002-08-20 Letter
Drug Adverse Effects information for LEUSTATIN
Role code
Indications
Reaction
# Reports
PS
HAIRY CELL LEUKAEMIA
MIXED OLIGO-ASTROCYTOMA
1
Ads by Google